SYNLOGIC, INC. Contract with Customer, Liability, Noncurrent
SYNLOGIC, INC. (SYBX) had Contract with Customer, Liability, Noncurrent of $465.00 thousand as of 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2019-05-09
- 2019-03-31: Contract with Customer, Liability, Noncurrent $465.00K.
- 2017-12-31: Contract with Customer, Liability, Noncurrent $668.00K.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2019-03-31 | $465.00K 10-Q · filed 2019-05-09 |
| 2017-12-31 | $668.00K 10-K · filed 2019-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |